Curaleaf Holdings, Inc. (CSE: CURA OTCQX: CURLF) (“Curaleaf” or the “Company”) a leading vertically integrated cannabis operator in the United States today announced that Boris Jordan Curaleaf Executive Chairman of the Board, will be delivering the keynote presentation at the Benzinga Virtual Cannabis Capital Conference at 10:15 am ET on Thursday, October 15, 2020 . The keynote presentation discussion will be moderated by Jason Raznick Benzinga Chief Executive Officer.  Curaleaf senior management will also be conducting virtual one-on-one investor meetings as well as a virtual investor group deskside presentation on Thursday, October 15, 2020 in conjunction with Stifel GMP.

To register and access the Curaleaf webcast presentation at the Benzinga Virtual Cannabis Capital Conference please visit the Curaleaf investor relations website at https://ir.curaleaf.com/events .


About Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading vertically integrated U.S. multi-state cannabis operator with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. Curaleaf currently operates in 23 states with 95 dispensaries, 22 cultivation sites and over 30 processing sites, and employs over 3,000 people across the United States . Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information please visit www.curaleaf.com .

INVESTOR CONTACT
Curaleaf Holdings, Inc.
Dan Foley , VP, Finance and Investor Relations
IR@curaleaf.com

MEDIA CONTACT
Curaleaf Holdings, Inc.
Tracy Brady , VP Corporate Communications
media@curaleaf.com

Cision View original content: http://www.prnewswire.com/news-releases/curaleaf-announces-keynote-presentation-at-the-benzinga-virtual-cannabis-capital-conference-301152327.html

SOURCE Curaleaf Holdings, Inc.

News Provided by Canada Newswire via QuoteMedia

The 2020 US presidential election looks set to stand the test of time as one of the most critical votes for the American people.

In addition to deciding the immediate future of the country, this election has many potential ramifications when it comes to the cannabis industry.

Keep reading... Show less

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Aurora Cannabis, Inc. (NYSE: ACB), Credit Acceptance Corporation (NASDAQ: CACC), Precigen, Inc. fka Intrexon Corporation (NASDAQ: PGEN; XON), and Royal Caribbean Group (NYSE: RCL). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Aurora Cannabis, Inc. (NYSE: ACB)

Keep reading... Show less

Pomerantz LLP announces that a class action lawsuit has been filed against certain officers of Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB). The class action, filed in United States District Court for the District of New Jersey, and docketed under 20-cv-13819, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise, acquired Aurora securities between February 13, 2020, and September 4, 2020, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

If you are a shareholder who purchased Aurora securities during the class period, you have until December 1, 2020, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

Keep reading... Show less

(V)ia SPRIZAs Are The First Products From Hill Street‘s New Wholly-Owned Subsidiary, Hill Avenue Cannabis Company

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”), is announcing the launch of its highly anticipated Hill Avenue Cannabis Co. (V)ia line-up of cannabis infused beverages. Hill Avenue Cannabis Co. is Hill Street‘s wholly-owned subsidiary focusing on cannabis infused beverages, drink mixes, tablets, capsules, and leading infusion ingredients intended to create world class Cannabis 2.0 edibles and topicals.

Keep reading... Show less

** THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.**

Harvest Health & Recreation Inc. (“Harvest” or the “Company”)   ( CSE: HARV ), a vertically integrated cannabis company and multi-state operator in the U.S., is pleased to announce that is has entered into an agreement pursuant to which Eight Capital, as lead agent and bookrunner, together with a syndicate of underwriters (collectively, the “ Underwriters ”), will purchase on a “bought deal” basis 13,274,400 units of the Company (“the Units ”) at a price of $2.26 per Unit (the “ Offering Price ) for aggregate gross proceeds to Harvest of $30,000,144 (the “ Offering ”). (All figures are in Canadian dollars unless otherwise stated.)

Keep reading... Show less